封面
市場調查報告書
商品編碼
1936735

全球磁振造影導引神經外科消融市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global MRI Guided Neurosurgical Ablation Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計 MRI 導引神經外科消融市場規模將從 2025 年的 7,763.7 億美元成長到 2034 年的 15,701.7 億美元,2026 年至 2034 年的複合年成長率為 8.14%。

由於神經系統疾病盛行率不斷上升以及對微創手術技術的需求日益成長,全球磁振造影引導神經外科消融市場預計將迎來顯著成長。磁振造影引導神經外科消融術利用磁振造影(MRI)引導消融手術,為腫瘤、癲癇和慢性疼痛等疾病提供精準有效的治療方法。該技術不僅提高了手術精度,還能最大限度地減少對周圍健康組織的損傷,從而改善患者預後並縮短復原時間。隨著醫療機構尋求應用更先進的治療方法,對磁振造影導引神經外科消融術的需求預計將顯著成長。

此外,磁振造影(MRI)和消融技術的進步預計將進​​一步推動市場發展。高場MRI系統和創新消融設備的研發提升了神經外科醫師的能力,使他們能夠更精準地完成更複雜的手術。同時,即時成像和導航系統的整合也提高了神經外科手術的安全性和有效性。隨著研究不斷發現MRI引導消融的新應用領域,市場有望湧現大量創新解決方案,以滿足患者和醫療服務提供者不斷變化的需求。

此外,以患者為中心的醫療保健理念日益受到重視,以及降低醫療成本的趨勢,預計將塑造磁振造影引導神經外科消融術市場的未來。隨著患者對治療方案的了解增多,他們對微創手術和縮短住院時間的需求也日益成長。磁振造影導引神經外科消融術恰好滿足了這些需求,並提供了一種有效的治療選擇,能夠提高患者滿意度。醫療設備製造商、醫療服務提供者和監管機構之間的合作對於推動這些創新至關重要,並確保磁振造影引導神經外科消融術市場能夠持續適應不斷變化的神經外科和患者照護需求。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球磁振造影導引神經外科消融市場(依產品分類)

  • 市場分析、洞察與預測
  • 磁共振導引射頻消融系統
  • 磁振造影導引雷射消熔系統
  • 磁共振引導聚焦超音波系統
  • 配件

5. 全球MRI導引神經外科消融市場(依最終用途分類)

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 門診手術中心

6. 全球MRI引導神經外科消融市場(按地區分類)

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商格局(基於現有資訊)
  • 策略規劃

第8章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Siemens Healthineers AG
    • Monteri
    • Profound Medical
    • Insightec
    • Medtronic
    • Boston Scientific Corporation
    • AngioDynamics
    • ClearPoint Neuro Inc
    • Elekta
    • Accuray Incorporated
簡介目錄
Product Code: VMR11212301

The MRI Guided Neurosurgical Ablation Market size is expected to reach USD 1570.17 Billion in 2034 from USD 776.37 Billion (2025) growing at a CAGR of 8.14% during 2026-2034.

The global MRI-guided neurosurgical ablation market is set to experience substantial growth, driven by the increasing prevalence of neurological disorders and the rising demand for minimally invasive surgical techniques. MRI-guided neurosurgical ablation offers a precise and effective approach to treating conditions such as tumors, epilepsy, and chronic pain by utilizing magnetic resonance imaging to guide the ablation process. This technology not only enhances the accuracy of the procedure but also minimizes damage to surrounding healthy tissue, leading to improved patient outcomes and faster recovery times. As healthcare providers seek to adopt advanced treatment modalities, the demand for MRI-guided neurosurgical ablation is expected to rise significantly.

Moreover, advancements in MRI technology and ablation techniques are anticipated to further boost the market. The development of high-field MRI systems and innovative ablation devices is enhancing the capabilities of neurosurgeons, allowing for more complex procedures to be performed with greater precision. Additionally, the integration of real-time imaging and navigation systems is improving the safety and efficacy of neurosurgical interventions. As research continues to uncover new applications for MRI-guided ablation, the market is likely to witness an influx of innovative solutions that cater to the evolving needs of patients and healthcare providers.

In addition, the growing emphasis on patient-centric care and the increasing focus on reducing healthcare costs are expected to shape the future of the MRI-guided neurosurgical ablation market. As patients become more informed about their treatment options, there is a rising demand for procedures that offer minimal invasiveness and shorter hospital stays. MRI-guided neurosurgical ablation aligns with these preferences, providing effective treatment options that enhance patient satisfaction. Collaborative efforts between medical device manufacturers, healthcare providers, and regulatory bodies will be essential in driving these innovations, ensuring that the MRI-guided neurosurgical ablation market remains responsive to the evolving landscape of neurosurgery and patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems
  • Accessories

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

COMPANIES PROFILED

  • Siemens Healthineers AG, Monteri, Profound Medical, Insightec, Medtronic, Boston Scientific Corporation, AngioDynamics, ClearPoint Neuro Inc, Elekta, Accuray Incorporated

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. MRI Guided RF Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. MRI Guided Laser Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. MRI Guided Focused Ultrasound Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MRI GUIDED NEUROSURGICAL ABLATION INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Siemens Healthineers AG
    • 8.2.2 Monteri
    • 8.2.3 Profound Medical
    • 8.2.4 Insightec
    • 8.2.5 Medtronic
    • 8.2.6 Boston Scientific Corporation
    • 8.2.7 AngioDynamics
    • 8.2.8 ClearPoint Neuro Inc
    • 8.2.9 Elekta
    • 8.2.10 Accuray Incorporated